
    
      This was a single centre, two-way crossover, randomised, open-label study in 24 healthy
      volunteers. The volunteers will receive an oral single-dose of simvastatin 80 mg on two
      occasions - once administered alone and once after treatment with an oral once-daily dose of
      800 mg of ESL for 14 days -, separated by a washout period of 3 weeks or more
    
  